These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3480820)

  • 41. Prevention and Treatment of Respiratory Distress Syndrome in Preterm Neonates.
    McPherson C; Wambach JA
    Neonatal Netw; 2018 May; 37(3):169-177. PubMed ID: 29789058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of glucocorticoids in preventing the idiopathic respiratory distress syndrome in low-weight infants].
    Ognianov K; Dimitrov M; Daskalova E
    Akush Ginekol (Sofiia); 1978; 17(3):157-60. PubMed ID: 354423
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevention and treatment of fetal lung immaturity.
    Cosmi EV; Di Renzo GC
    Fetal Ther; 1989; 4 Suppl 1():52-62. PubMed ID: 2577304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hormonal influences during fetal lung development.
    Ballard PL
    Ciba Found Symp; 1980; 78():251-74. PubMed ID: 6907082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prenatal corticotherapy and acceleration of fetal maturation. II. Results of clinical applications].
    Lacaze-Masmonteil T
    Arch Pediatr; 1996 Nov; 3(11):1119-28. PubMed ID: 8952778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antenatal modes of surfactant administration for RDS prevention: a review.
    Ostrzenski A; Radolinski B; Ostrzenska KM
    J Natl Med Assoc; 2006 Mar; 98(3):340-4. PubMed ID: 16573296
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Use of glucocorticoids in prevention of the respiratory distress syndrome].
    de Oliveira RL; dos Santos MC; Candido DF; el'Debs I
    Rev Centro Cienc Biomed Univ Fed Uberlandia; 1987 Dec; 3(1):41-7. PubMed ID: 3078405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fetal lung maturation and the antenatal use of glucocorticoids to prevent the respiratory distress syndrome.
    Shields JR; Resnik R
    Obstet Gynecol Surv; 1979 May; 34(5):343-63. PubMed ID: 379720
    [No Abstract]   [Full Text] [Related]  

  • 49. The use of exogenous maternal glucocorticoids to prevent neonatal respiratory distress syndrome (RDS)--the state of the facts.
    Zachman RD
    Wis Med J; 1976 Sep; 75(9):S91-2. PubMed ID: 969558
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pulmonary surfactant in fetuses and newborn infants. Metabolic maturation of pneumocytes and the role of surfactant proteins].
    Groniowski J
    Patol Pol; 1989; 40(1):1-16. PubMed ID: 2797910
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharyngeal deposition of surfactant in the premature rabbit fetus.
    Enhörning G; Grossmann G; Robertson B
    Biol Neonate; 1973; 22(1):126-32. PubMed ID: 4489637
    [No Abstract]   [Full Text] [Related]  

  • 52. Prevention of respiratory distress syndrome.
    Moya FR; Gross I
    Semin Perinatol; 1988 Oct; 12(4):348-58. PubMed ID: 3146813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maternal administration of glucocorticoids.
    Beck JC; Johnson JW
    Clin Obstet Gynecol; 1980 Mar; 23(1):93-113. PubMed ID: 6988134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chevalier Jackson Lecture: In quest of the prevention of hyaline membrane disease.
    Avery ME
    Ann Otol Rhinol Laryngol; 1977; 86(5 Pt 1):573-6. PubMed ID: 578667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antenatal steroids and the IUGR fetus: are exposure and physiological effects on the lung and cardiovascular system the same as in normally grown fetuses?
    Morrison JL; Botting KJ; Soo PS; McGillick EV; Hiscock J; Zhang S; McMillen IC; Orgeig S
    J Pregnancy; 2012; 2012():839656. PubMed ID: 23227338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrafetal glucose infusion alters glucocorticoid signaling and reduces surfactant protein mRNA expression in the lung of the late-gestation sheep fetus.
    McGillick EV; Morrison JL; McMillen IC; Orgeig S
    Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(5):R538-45. PubMed ID: 24990855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study of the functional role of phospholipids in pulmonary surfactants. Importance in perinatology].
    Labbé A; Motta C; Storme B; Touillon AM; Assali P; Gaulme J; Raynaud EJ
    Ann Pediatr (Paris); 1988 Feb; 35(2):97-100. PubMed ID: 3284432
    [No Abstract]   [Full Text] [Related]  

  • 58. The respiratory distress syndrome and glcocorticoid treatment: the case for enzyme induction.
    Nathan DM
    Mt Sinai J Med; 1975; 42(2):150-66. PubMed ID: 1094274
    [No Abstract]   [Full Text] [Related]  

  • 59. [Characteristics of phospholipids of pharyngeal aspirates in newborn infants depending on the use of glucocorticoids in the prenatal period for the prevention of respiratory disorders].
    Kuptsov VA
    Pediatriia; 1984 Mar; (3):32-4. PubMed ID: 6718156
    [No Abstract]   [Full Text] [Related]  

  • 60. Prenatal prevention of respiratory distress syndrome: new pharmacologic approaches.
    Cosmi EV
    Early Hum Dev; 1992; 29(1-3):283-6. PubMed ID: 1396253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.